Mertsoylu, H.Kose, F.Sedef, A.M.Dogan, O.Parlak, C.Besen, A.A.Sumbul, A.T.Findikcioglu, A.Sezer, A.Muallaoglu, S.2019-11-272019-11-2720150923-7534https://watermark.silverchair.com/mdv049.10.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAnAwggJsBgkqhkiG9w0BBwagggJdMIICWQIBADCCAlIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMLZMV1soP30RZ5jGrAgEQgIICI-iC_DODl3EFNA5CD0zvxpPDSkpuELH4qYcPSy2uPW67ffSPwbkOGE-fj04nVQ5Sz1x3smFJAey71oj6nfm5NBa94G6toCKdYFgDIUFP_NQ3oZBWdzBxq17CdXjfcUsOS37m4aGpJmpvhV_KDUHX4iTRJDiaQ-cUFXc8Mu-CvNjkfDiij3oz7YcwnrWbyx7cr_peIfjN0rj411fe1In-W2QxP_kMI-9yP92WRlCx8dXeWgJvpClgekEHVTxnajpT3PLDmU46myyUOW9ksTkwI7bu0yNKEZGDOxNVzRJBXFHYqTW0C2Bzt5EaEQRw8kFnJqON0lleJpCakSxqEJcZb3PZ3FB3eBg303faOngXPwpbsbIRqYPt8xDbWJYhs4VWumpBbjIH5i_K5GGCIfGCDw7K3LN3KJrMiL8Hzyp6Z-UCkUBP5GHmpe74ERZ0rQn1ET0zQ7IQihq4b-UgT6tBwpzUxl9ZzC1sKhLMIvtl66oYCex1Cepjo5tt-HgID2vBtlmlF6YXKBa10T2S5DbxrJCxRneqAf0dhxF52lzwEIyTKHhfMooSDzH7SaKLJ6mA7qYUV3O5Uzy04fDDyBWXt-DWM-qRN6BCDCaPc__CTs-Wh0BfoJucdiRqTNmGN5RRFmN2NjoFwnb4BXoPeIoIsjVZr_aCbQhDisfYHRR0mkVumMXrKDb38UcFCIoNkf6UdTqyDo8mFUdimWHbr3NaoJujDXchttp://hdl.handle.net/11727/4288enginfo:eu-repo/semantics/openAccessCONCURRENT CHEMORADIOTHERAPY WITH VINORELBINE PLUS SPLIT-DOSE CISPLATIN IN INOPERABLE STAGE III NON-SMALL CELL LUNG CANCERconferenceObject26000354728700039